CFTR GI:90421313 cystic fibrosis transmembrane conductance regulator 1 mqrsplekas vvsklffswt rpilrkgyrq rlelsdiyqi psvdsadnls 50 51 eklerewdre laskknpkli nalrrcffwr fmfygiflyl gevtkavqpl 100 101 llgriiasyd pdnkeersia iylgiglcll fivrtlllhp aifglhhigm 150 151 qmriamfsli ykktlklssr vldkisigql vsllsnnlnk fdeglalahf 200 201 vwiaplqval lmgliwellq asafcglgfl ivlalfqagl grmmmkyrdq 250 251 ragkiserlv itsemieniq svkaycweea mekmienlrq telkltrkaa 300 301 yvryfnssaf ffsgffvvfl svlpyalikg iilrkiftti sfcivlrmav 350 351 trqfpwavqt wydslgaink iqdflqkqey ktleynlttt evvmenvtaf 400 401 weegfgelfe kakqnnnnrk tsngddslff snfsllgtpv lkdinfkier 450 451 gqllavagst gagktsllmv imgelepseg kikhsgrisf csqfswimpg 500 501 tikeniifgv sydeyryrsv ikacqleedi skfaekdniv lgeggitlsg 550 551 gqrarislar avykdadlyl ldspfgyldv ltekeifesc vcklmanktr 600 601 ilvtskmehl kkadkililh egssyfygtf selqnlqpdf ssklmgcdsf 650 651 dqfsaerrns iltetlhrfs legdapvswt etkkqsfkqt gefgekrkns 700 701 ilnpinsirk fsivqktplq mngieedsde plerrlslvp dseqgeailp 750 751 risvistgpt lqarrrqsvl nlmthsvnqg qnihrkttas trkvslapqa 800 801 nlteldiysr rlsqetglei seeineedlk ecffddmesi pavttwntyl 850 851 ryitvhksli fvliwclvif laevaaslvv lwllgntplq dkgnsthsrn 900 901 nsyaviitst ssyyvfyiyv gvadtllamg ffrglplvht litvskilhh 950 951 kmlhsvlqap mstlntlkag gilnrfskdi ailddllplt ifdfiqllli 1000 1001 vigaiavvav lqpyifvatv pvivafimlr ayflqtsqql kqlesegrsp 1050 1051 ifthlvtslk glwtlrafgr qpyfetlfhk alnlhtanwf lylstlrwfq 1100 1101 mriemifvif fiavtfisil ttgegegrvg iiltlamnim stlqwavnss 1150 1151 idvdslmrsv srvfkfidmp tegkptkstk pykngqlskv miienshvkk 1200 1201 ddiwpsggqm tvkdltakyt eggnaileni sfsispgqrv gllgrtgsgk 1250 1251 stllsaflrl lntegeiqid gvswdsitlq qwrkafgvip qkvfifsgtf 1300 1301 rknldpyeqw sdqeiwkvad evglrsvieq fpgkldfvlv dggcvlshgh 1350 1351 kqlmclarsv lskakillld epsahldpvt yqiirrtlkq afadctvilc 1400 1401 ehrieamlec qqflvieenk vrqydsiqkl lnerslfrqa ispsdrvklf 1450 1451 phrnsskcks kpqiaalkee teeevqdtrl